|
1
|
Aagaard L and Rossi JJ: RNAi therapeutics:
Principles, prospects and challenges. Adv Drug Deliv Rev. 59:75–86.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aigner A: Applications of RNA
interference: Current state and prospects for siRNA-based
strategies in vivo. Appl Microbiol Biotechnol. 76:9–21. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Uprichard SL: The therapeutic potential of
RNA interference. FEBS Lett. 579:5996–6007. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leenders F, Möpert K, Schmiedeknecht A,
Santel A, Czauderna F, Aleku M, Penschuck S, Dames S, Sternberger
M, Röhl T, et al: PKN3 is required for malignant prostate cell
growth downstream of activated PI 3-kinase. EMBO J. 23:3303–3313.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aleku M, Schulz P, Keil O, Santel A,
Schaeper U, Dieckhoff B, Janke O, Endruschat J, Durieux B, Röder N,
et al: Atu027, a liposomal small interfering RNA formulation
targeting protein kinase N3, inhibits cancer progression. Cancer
Res. 68:9788–9798. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Santel A, Aleku M, Röder N, Möpert K,
Durieux B, Janke O, Keil O, Endruschat J, Dames S, Lange C, et al:
Atu027 prevents pulmonary metastasis in experimental and
spontaneous mouse metastasis models. Clin Cancer Res. 16:5469–5480.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Strumberg D, Schultheis B, Traugott U,
Vank C, Santel A, Keil O, Giese K, Kaufmann J and Drevs J: Phase I
clinical development of Atu027, a siRNA formulation targeting PKN3
in patients with advanced solid tumors. Int J Clin Pharmacol Ther.
50:76–78. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Taetz S, Bochot A, Surace C, Arpicco S,
Renoir JM, Schaefer UF, Marsaud V, Kerdine-Roemer S, Lehr CM and
Fattal E: Hyaluronic acid-modified DOTAP/DOPE liposomes for the
targeted delivery of anti-telomerase siRNA to CD44-expressing lung
cancer cells. Oligonucleotides. 19:103–116. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Wolf HK, Snel CJ, Verbaan FJ,
Schiffelers RM, Hennink WE and Storm G: Effect of cationic carriers
on the pharmacokinetics and tumor localization of nucleic acids
after intravenous administration. Int J Pharm. 331:167–175. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cardoso AL, Simões S, de Almeida LP,
Plesnila N, de Lima Pedroso MC, Wagner E and Culmsee C:
Tf-lipoplexes for neuronal siRNA delivery: A promising system to
mediate gene silencing in the CNS. J Control Release. 132:113–123.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hattori Y, Nakamura A, Arai S, Kawano K,
Maitani Y and Yonemochi E: siRNA delivery to lung-metastasized
tumor by systemic injection with cationic liposomes. J Liposome
Res. 25:279–286. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eliyahu H, Servel N, Domb AJ and Barenholz
Y: Lipoplex-induced hemagglutination: Potential involvement in
intravenous gene delivery. Gene Ther. 9:850–858. 2002.PubMed/NCBI
|
|
13
|
Simberg D, Weisman S, Talmon Y, Faerman A,
Shoshani T and Barenholz Y: The role of organ vascularization and
lipoplex-serum initial contact in intravenous murine lipofection. J
Biol Chem. 278:39858–39865. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hattori Y, Arai S, Kikuchi T, Ozaki K,
Kawano K and Yonemochi E: Therapeutic effect for liver-metastasized
tumor by sequential intravenous injection of anionic polymer and
cationic lipoplex of siRNA. J Drug Target. 24:309–317. 2016.
View Article : Google Scholar
|
|
15
|
Hattori Y, Arai S, Okamoto R, Hamada M,
Kawano K and Yonemochi E: Sequential intravenous injection of
anionic polymer and cationic lipoplex of siRNA could effectively
deliver siRNA to the liver. Int J Pharm. 476:289–298. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kato M, Hattori Y, Kubo M and Maitani Y:
Collagenase-1 injection improved tumor distribution and gene
expression of cationic lipoplex. Int J Pharm. 423:428–434. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Taniguchi Y, Kawano K, Minowa T, Sugino T,
Shimojo Y and Maitani Y: Enhanced antitumor efficacy of
folate-linked liposomal doxorubicin with TGF-β type I receptor
inhibitor. Cancer Sci. 101:2207–2213. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Unsal-Kacmaz K, Ragunathan S, Rosfjord E,
Dann S, Upeslacis E, Grillo M, Hernandez R, Mack F and Klippel A:
The interaction of PKN3 with RhoC promotes malignant growth. Mol
Oncol. 6:284–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Palmer RH, Ridden J and Parker PJ: Cloning
and expression patterns of two members of a novel
protein-kinase-C-related kinase family. Eur J Biochem. 227:344–351.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lachmann S, Jevons A, De Rycker M,
Casamassima A, Radtke S, Collazos A and Parker PJ: Regulatory
domain selectivity in the cell-type specific PKN-dependence of cell
migration. PLoS One. 6:e217322011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goel S, Duda DG, Xu L, Munn LL, Boucher Y,
Fukumura D and Jain RK: Normalization of the vasculature for
treatment of cancer and other diseases. Physiol Rev. 91:1071–1121.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weis SM and Cheresh DA: Pathophysiological
consequences of VEGF-induced vascular permeability. Nature.
437:497–504. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pinon P and Wehrle-Haller B: Integrins:
Versatile receptors controlling melanocyte adhesion, migration and
proliferation. Pigment Cell Melanoma Res. 24:282–294. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Laurent VM, Duperray A, Rajan Sundar V and
Verdier C: Atomic force microscopy reveals a role for endothelial
cell ICAM-1 expression in bladder cancer cell adherence. PLoS One.
9:e980342014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jimenez D, Roda-Navarro P, Springer TA and
Casasnovas JM: Contribution of N-linked glycans to the conformation
and function of intercellular adhesion molecules (ICAMs). J Biol
Chem. 280:5854–5861. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mukai H, Muramatsu A, Mashud R, Kubouchi
K, Tsujimoto S, Hongu T, Kanaho Y, Tsubaki M, Nishida S, Shioi G,
et al: PKN3 is the major regulator of angiogenesis and tumor
metastasis in mice. Sci Rep. 6:189792016. View Article : Google Scholar : PubMed/NCBI
|
